Tag : II

Biology

NeuroFlow Awarded $750K from the National Science Foundation for SBIR Phase II

Newsemia
PHILADELPHIA (PRWEB) April 17, 2020 NeuroFlow has been awarded $750,000 from the National Science Foundation (NSF) Small Business Innovation Research (SBIR) program to support the...
Latest News

ImmunoGen Presents Initial Data from Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab Soravtansine in Combination with Carboplatin and Avastin® at ESMO

Newsemia
WALTHAM, Mass.–(BUSINESS WIRE)–IMGN Presents Initial Data from Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab in Combination with Carboplatin and Avastin® at ESMO Source link...
Biology

A Photosynthesis-Specific Rubredoxin-Like Protein Is Required for Efficient Association of the D1 and D2 Proteins during the Initial Steps of Photosystem II Assembly

Newsemia
Oxygenic photosynthesis relies on accessory factors to promote the assembly and maintenance of the photosynthetic apparatus in the thylakoid membranes. The highly conserved membrane-bound rubredoxin-like...
Pharma / Biotech

Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial.

Newsemia
Related Articles Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory...
Latest News

Riassunto: Solasia annuncia che la registrazioni di pazienti ha raggiunto il numero prefissato di casi per lo studio definitivo di Fase II su darinaparsin per il trattamento di pazienti affetti da linfoma a cellule T

Newsemia
TOKYO–(BUSINESS WIRE)–Solasia Pharma K.K. (TSE:4597, Direzione generale: Tokyo, Presidente e Direttore generale: Yoshihiro Arai, nel seguito denominata “Solasia”), una società asiatica impegnata nello sviluppo di...
Latest News

Molecular Recognition of Lipid II by Lantibiotics: Synthesis and Conformational Studies of Analogues of Nisin and Mutacin Rings A and B

Newsemia
Dickman, R; Mitchell, SA; Figueiredo, AM; Hansen, DF; Tabor, AB; (2019) Molecular Recognition of Lipid II by Lantibiotics: Synthesis and Conformational Studies of Analogues of...
Latest News

The absence of [C II] 158 μm emission in spectroscopically confirmed galaxies at z > 8

Newsemia
Laporte, N; Katz, H; Ellis, RS; Lagache, G; Bauer, FE; Boone, F; Inoue, AK; … Tamura, Y; + view all Laporte, N; Katz, H; Ellis,...
Latest News

Uncertainty quantification for radio interferometric imaging: II. MAP estimation

Newsemia
Cai, X; Pereyra, M; McEwen, JD; (2018) Uncertainty quantification for radio interferometric imaging: II. MAP estimation. Monthly Notices of the Royal Astronomical Society , 480...
Latest News

Another myeloma drug with same target as CAR-Ts shows successful Phase II results

Newsemia
Without providing details, GlaxoSmithKline said its trial of BCMA-targeting belantamab mafodotin was positive. The company plans to submit for regulatory approvals later this year –...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy